Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Epirus Biopharma (EPRSQ)
OTHER OTC:EPRSQ
Epirus Biopharma (EPRSQ) Stock Price & Analysis
20 Followers
EPRSQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.00 - $1.00
Previous Close$0.5
Volume3.00
Average Volume (3M)N/A
Market Cap
$26.00
Enterprise Value-$6.01M
Total Cash (Recent Filing)$20.86M
Total Debt (Recent Filing)$14.85M
Price to Earnings (P/E)N/A
Beta9.58
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation13.05
R-Squared0.00321
Alpha2.09
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-4.07
Enterprise Value/Gross Profit-10.44
Enterprise Value/Ebitda0.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPRSQ FAQ
What was Epirus Biopharma’s price range in the past 12 months?
Epirus Biopharma lowest stock price was $0.00 and its highest was $1.00 in the past 12 months.
What is Epirus Biopharma’s market cap?
Currently, no data Available
When is Epirus Biopharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Epirus Biopharma’s earnings last quarter?
Currently, no data Available
Is Epirus Biopharma overvalued?
According to Wall Street analysts Epirus Biopharma’s price is currently Overvalued.
Does Epirus Biopharma pay dividends?
Epirus Biopharma does not currently pay dividends.
What is Epirus Biopharma’s EPS estimate?
Epirus Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epirus Biopharma have?
Epirus Biopharma has 26,184,000 shares outstanding.
What happened to Epirus Biopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Epirus Biopharma?
Currently, no hedge funds are holding shares in EPRSQ
---
Company Description
Epirus Biopharma
EPIRUS Biopharmaceuticals, Inc. is a biopharmaceutical company, which focuses on building a biosimilar business. It focuses on biosimilars, which are biologic drugs that are demonstrated to be highly similar to a previously approved biologic drug, known as a reference product. The company was founded on November 26, 2008 and is headquartered in Boston, MA.
---
Technical Analysis
Achieve Life Sciences
―
Apellis Pharmaceuticals
―
Ardelyx
―
Aurinia Pharmaceuticals
―
---